List of Tables
Table 1. Global Anti-Infective Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Penicillin
Table 3. Key Players of Sulphonamides
Table 4. Key Players of Aminoglycosides
Table 5. Key Players of Fluoroquinolones
Table 6. Key Players of Antifungals
Table 7. Key Players of Antiprotozoal
Table 8. Key Players of Others
Table 9. Global Anti-Infective Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 10. Global Anti-Infective Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 11. Global Anti-Infective Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 12. Global Anti-Infective Therapy Market Share by Region (2020-2025)
Table 13. Global Anti-Infective Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 14. Global Anti-Infective Therapy Market Share by Region (2026-2031)
Table 15. Anti-Infective Therapy Market Trends
Table 16. Anti-Infective Therapy Market Drivers
Table 17. Anti-Infective Therapy Market Challenges
Table 18. Anti-Infective Therapy Market Restraints
Table 19. Global Anti-Infective Therapy Revenue by Players (2020-2025) & (US$ Million)
Table 20. Global Anti-Infective Therapy Market Share by Players (2020-2025)
Table 21. Global Top Anti-Infective Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Infective Therapy as of 2024)
Table 22. Ranking of Global Top Anti-Infective Therapy Companies by Revenue (US$ Million) in 2024
Table 23. Global 5 Largest Players Market Share by Anti-Infective Therapy Revenue (CR5 and HHI) & (2020-2025)
Table 24. Global Key Players of Anti-Infective Therapy, Headquarters and Area Served
Table 25. Global Key Players of Anti-Infective Therapy, Product and Application
Table 26. Global Key Players of Anti-Infective Therapy, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Anti-Infective Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 29. Global Anti-Infective Therapy Revenue Market Share by Type (2020-2025)
Table 30. Global Anti-Infective Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 31. Global Anti-Infective Therapy Revenue Market Share by Type (2026-2031)
Table 32. Global Anti-Infective Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 33. Global Anti-Infective Therapy Revenue Market Share by Application (2020-2025)
Table 34. Global Anti-Infective Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 35. Global Anti-Infective Therapy Revenue Market Share by Application (2026-2031)
Table 36. North America Anti-Infective Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. North America Anti-Infective Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 38. North America Anti-Infective Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 39. Europe Anti-Infective Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 40. Europe Anti-Infective Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 41. Europe Anti-Infective Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 42. Asia-Pacific Anti-Infective Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 43. Asia-Pacific Anti-Infective Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 44. Asia-Pacific Anti-Infective Therapy Market Size by Region (2026-2031) & (US$ Million)
Table 45. Latin America Anti-Infective Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Latin America Anti-Infective Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 47. Latin America Anti-Infective Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 48. Middle East & Africa Anti-Infective Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 49. Middle East & Africa Anti-Infective Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 50. Middle East & Africa Anti-Infective Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 51. Abbott Laboratories Ltd. Company Details
Table 52. Abbott Laboratories Ltd. Business Overview
Table 53. Abbott Laboratories Ltd. Anti-Infective Therapy Product
Table 54. Abbott Laboratories Ltd. Revenue in Anti-Infective Therapy Business (2020-2025) & (US$ Million)
Table 55. Abbott Laboratories Ltd. Recent Development
Table 56. Cipla Ltd. Company Details
Table 57. Cipla Ltd. Business Overview
Table 58. Cipla Ltd. Anti-Infective Therapy Product
Table 59. Cipla Ltd. Revenue in Anti-Infective Therapy Business (2020-2025) & (US$ Million)
Table 60. Cipla Ltd. Recent Development
Table 61. Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris)) Company Details
Table 62. Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris)) Business Overview
Table 63. Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris)) Anti-Infective Therapy Product
Table 64. Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris)) Revenue in Anti-Infective Therapy Business (2020-2025) & (US$ Million)
Table 65. Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris)) Recent Development
Table 66. Glenmark Pharmaceuticals Limited Company Details
Table 67. Glenmark Pharmaceuticals Limited Business Overview
Table 68. Glenmark Pharmaceuticals Limited Anti-Infective Therapy Product
Table 69. Glenmark Pharmaceuticals Limited Revenue in Anti-Infective Therapy Business (2020-2025) & (US$ Million)
Table 70. Glenmark Pharmaceuticals Limited Recent Development
Table 71. GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd) Company Details
Table 72. GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd) Business Overview
Table 73. GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd) Anti-Infective Therapy Product
Table 74. GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd) Revenue in Anti-Infective Therapy Business (2020-2025) & (US$ Million)
Table 75. GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd) Recent Development
Table 76. Lupin Limited Company Details
Table 77. Lupin Limited Business Overview
Table 78. Lupin Limited Anti-Infective Therapy Product
Table 79. Lupin Limited Revenue in Anti-Infective Therapy Business (2020-2025) & (US$ Million)
Table 80. Lupin Limited Recent Development
Table 81. Panacea Biotec Limited Company Details
Table 82. Panacea Biotec Limited Business Overview
Table 83. Panacea Biotec Limited Anti-Infective Therapy Product
Table 84. Panacea Biotec Limited Revenue in Anti-Infective Therapy Business (2020-2025) & (US$ Million)
Table 85. Panacea Biotec Limited Recent Development
Table 86. Novartis AG Company Details
Table 87. Novartis AG Business Overview
Table 88. Novartis AG Anti-Infective Therapy Product
Table 89. Novartis AG Revenue in Anti-Infective Therapy Business (2020-2025) & (US$ Million)
Table 90. Novartis AG Recent Development
Table 91. Pfizer, Inc. Company Details
Table 92. Pfizer, Inc. Business Overview
Table 93. Pfizer, Inc. Anti-Infective Therapy Product
Table 94. Pfizer, Inc. Revenue in Anti-Infective Therapy Business (2020-2025) & (US$ Million)
Table 95. Pfizer, Inc. Recent Development
Table 96. Ranbaxy Laboratories Limited Company Details
Table 97. Ranbaxy Laboratories Limited Business Overview
Table 98. Ranbaxy Laboratories Limited Anti-Infective Therapy Product
Table 99. Ranbaxy Laboratories Limited Revenue in Anti-Infective Therapy Business (2020-2025) & (US$ Million)
Table 100. Ranbaxy Laboratories Limited Recent Development
Table 101. Sun Pharmaceutical Industries Limited Company Details
Table 102. Sun Pharmaceutical Industries Limited Business Overview
Table 103. Sun Pharmaceutical Industries Limited Anti-Infective Therapy Product
Table 104. Sun Pharmaceutical Industries Limited Revenue in Anti-Infective Therapy Business (2020-2025) & (US$ Million)
Table 105. Sun Pharmaceutical Industries Limited Recent Development
Table 106. AstraZeneca plc Company Details
Table 107. AstraZeneca plc Business Overview
Table 108. AstraZeneca plc Anti-Infective Therapy Product
Table 109. AstraZeneca plc Revenue in Anti-Infective Therapy Business (2020-2025) & (US$ Million)
Table 110. AstraZeneca plc Recent Development
Table 111. Johnson & Johnson Company Details
Table 112. Johnson & Johnson Business Overview
Table 113. Johnson & Johnson Anti-Infective Therapy Product
Table 114. Johnson & Johnson Revenue in Anti-Infective Therapy Business (2020-2025) & (US$ Million)
Table 115. Johnson & Johnson Recent Development
Table 116. WOCKHARDT Company Details
Table 117. WOCKHARDT Business Overview
Table 118. WOCKHARDT Anti-Infective Therapy Product
Table 119. WOCKHARDT Revenue in Anti-Infective Therapy Business (2020-2025) & (US$ Million)
Table 120. WOCKHARDT Recent Development
Table 121. F. Hoffmann-La Roche Ltd Company Details
Table 122. F. Hoffmann-La Roche Ltd Business Overview
Table 123. F. Hoffmann-La Roche Ltd Anti-Infective Therapy Product
Table 124. F. Hoffmann-La Roche Ltd Revenue in Anti-Infective Therapy Business (2020-2025) & (US$ Million)
Table 125. F. Hoffmann-La Roche Ltd Recent Development
Table 126. Sanofi Company Details
Table 127. Sanofi Business Overview
Table 128. Sanofi Anti-Infective Therapy Product
Table 129. Sanofi Revenue in Anti-Infective Therapy Business (2020-2025) & (US$ Million)
Table 130. Sanofi Recent Development
Table 131. Merck Company Details
Table 132. Merck Business Overview
Table 133. Merck Anti-Infective Therapy Product
Table 134. Merck Revenue in Anti-Infective Therapy Business (2020-2025) & (US$ Million)
Table 135. Merck Recent Development
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
Table 139. Authors List of This Report
List of Figures
Figure 1. Anti-Infective Therapy Picture
Figure 2. Global Anti-Infective Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Anti-Infective Therapy Market Share by Type: 2024 VS 2031
Figure 4. Penicillin Features
Figure 5. Sulphonamides Features
Figure 6. Aminoglycosides Features
Figure 7. Fluoroquinolones Features
Figure 8. Antifungals Features
Figure 9. Antiprotozoal Features
Figure 10. Others Features
Figure 11. Global Anti-Infective Therapy Market Size by Application (2020-2031) & (US$ Million)
Figure 12. Global Anti-Infective Therapy Market Share by Application: 2024 VS 2031
Figure 13. Home User Case Studies
Figure 14. Hospitals/Clinics Case Studies
Figure 15. Ambulatory Surgery Centres Case Studies
Figure 16. Others Case Studies
Figure 17. Anti-Infective Therapy Report Years Considered
Figure 18. Global Anti-Infective Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 19. Global Anti-Infective Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 20. Global Anti-Infective Therapy Market Share by Region: 2024 VS 2031
Figure 21. Global Anti-Infective Therapy Market Share by Players in 2024
Figure 22. Global Top Anti-Infective Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Infective Therapy as of 2024)
Figure 23. The Top 10 and 5 Players Market Share by Anti-Infective Therapy Revenue in 2024
Figure 24. North America Anti-Infective Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. North America Anti-Infective Therapy Market Share by Country (2020-2031)
Figure 26. United States Anti-Infective Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Canada Anti-Infective Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Europe Anti-Infective Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Europe Anti-Infective Therapy Market Share by Country (2020-2031)
Figure 30. Germany Anti-Infective Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. France Anti-Infective Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. U.K. Anti-Infective Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Italy Anti-Infective Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Russia Anti-Infective Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Nordic Countries Anti-Infective Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Asia-Pacific Anti-Infective Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Asia-Pacific Anti-Infective Therapy Market Share by Region (2020-2031)
Figure 38. China Anti-Infective Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Japan Anti-Infective Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. South Korea Anti-Infective Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Southeast Asia Anti-Infective Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. India Anti-Infective Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Australia Anti-Infective Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Latin America Anti-Infective Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Latin America Anti-Infective Therapy Market Share by Country (2020-2031)
Figure 46. Mexico Anti-Infective Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Brazil Anti-Infective Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Middle East & Africa Anti-Infective Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Middle East & Africa Anti-Infective Therapy Market Share by Country (2020-2031)
Figure 50. Turkey Anti-Infective Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Anti-Infective Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. UAE Anti-Infective Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 53. Abbott Laboratories Ltd. Revenue Growth Rate in Anti-Infective Therapy Business (2020-2025)
Figure 54. Cipla Ltd. Revenue Growth Rate in Anti-Infective Therapy Business (2020-2025)
Figure 55. Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris)) Revenue Growth Rate in Anti-Infective Therapy Business (2020-2025)
Figure 56. Glenmark Pharmaceuticals Limited Revenue Growth Rate in Anti-Infective Therapy Business (2020-2025)
Figure 57. GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd) Revenue Growth Rate in Anti-Infective Therapy Business (2020-2025)
Figure 58. Lupin Limited Revenue Growth Rate in Anti-Infective Therapy Business (2020-2025)
Figure 59. Panacea Biotec Limited Revenue Growth Rate in Anti-Infective Therapy Business (2020-2025)
Figure 60. Novartis AG Revenue Growth Rate in Anti-Infective Therapy Business (2020-2025)
Figure 61. Pfizer, Inc. Revenue Growth Rate in Anti-Infective Therapy Business (2020-2025)
Figure 62. Ranbaxy Laboratories Limited Revenue Growth Rate in Anti-Infective Therapy Business (2020-2025)
Figure 63. Sun Pharmaceutical Industries Limited Revenue Growth Rate in Anti-Infective Therapy Business (2020-2025)
Figure 64. AstraZeneca plc Revenue Growth Rate in Anti-Infective Therapy Business (2020-2025)
Figure 65. Johnson & Johnson Revenue Growth Rate in Anti-Infective Therapy Business (2020-2025)
Figure 66. WOCKHARDT Revenue Growth Rate in Anti-Infective Therapy Business (2020-2025)
Figure 67. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Anti-Infective Therapy Business (2020-2025)
Figure 68. Sanofi Revenue Growth Rate in Anti-Infective Therapy Business (2020-2025)
Figure 69. Merck Revenue Growth Rate in Anti-Infective Therapy Business (2020-2025)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
